(Q46314478)

English

Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Phase I trial of neoadjuvant chemoradiotherapy (CRT) with capecitabine and weekly irinotecan followed by laparoscopic total mesorectal excision (LTME) in rectal cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

chemoradiotherapy

0 references

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Antoni Castells

10

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

author name string

Lisardo Ugidos

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Salvadora Delgado

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Carlos Conill

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Angels Ginés

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Rosa Gallego

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Juan Ramón Ayuso

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Rosa Miquel

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Monica Tosca

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Antonio de Lacy

9

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Joan Maurel

11

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

publication date

16 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

27

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

262-268

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

Preoperative infusional chemoradiation therapy for Stage T3 rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-008-9192-6

21 January 2018

Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-008-9192-6

21 January 2018

Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-008-9192-6

21 January 2018

Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-008-9192-6

21 January 2018

Laparoscopic-assisted approach in rectal cancer patients: lessons learned from >200 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerase I-targeting drugs as radiation sensitizers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymph node clearance after total mesorectal excision for rectal cancer: laparoscopic versus open approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clarifying margins in the multidisciplinary management of rectal cancer: the MERCURY experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laparoscopic versus conventional open resection of rectal carcinoma: A clinical comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laparoscopic total mesorectal excision: a consecutive series of 100 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18923810

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-008-9192-6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18923810

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46314478&oldid=2207795091"